FDA Drug information
ARANESP
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- ARANESP DARBEPOETIN ALFA 10 ug/.4mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 100 ug/.5mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 100 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 150 ug/.3mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 200 ug/.4mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 200 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 25 ug/.42mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 25 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 300 ug/.6mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 300 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 40 ug/.4mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 40 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 500 ug/mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 60 ug/.3mL Amgen Inc
- ARANESP DARBEPOETIN ALFA 60 ug/mL Amgen Inc
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.